Skip to content

Novocure

US · NVCR #2889 by market cap Listed 2015
10.71 +0.02 +0.19%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Novocure

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, the United Kingdom.

Founded
2000
CEO
Mr. Francis Leonard
Employees
1,605
Headquarters
St. Helier, Jersey, United Kingdom of Great Britain and Northern Ireland (the)
Fiscal year end
12-31
Website
novocure.com

Company profile

Exchange
US
Symbol
NVCR
Market-cap rank
#2889
Listing date
2015-10-02
Market cap
1.25B
Float cap
1.04B
Shares out
116.92M
Float shares
97.39M

Sectors & themes

Medical Devices Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Novocure discussion 0 comments

Add a comment